Teprotumumab-Related Adverse Events in Thyroid Eye Disease: A Multicenter Study. Shah SA, Amarikwa L, Sears CM, Clauss KD, et al. Ophthalmology 2024;131:458-467.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shah SA, Amarikwa L, Sears CM, Clauss KD, et al. Teprotumumab-Related Adverse Events in Thyroid Eye Disease: A Multicenter Study. Ophthalmology 2024;131:458-467.
PMID: 37852417